These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16455704)
21. US judge dismisses 50m dollars damages in Vioxx lawsuit. Charatan F BMJ; 2006 Sep; 333(7567):516. PubMed ID: 16960199 [No Abstract] [Full Text] [Related]
22. Vioxx, the implosion of Merck, and aftershocks at the FDA. Horton R Lancet; 2004 Dec 4-10; 364(9450):1995-6. PubMed ID: 15582041 [No Abstract] [Full Text] [Related]
23. Was Vioxx really that dangerous? Park A Time; 2005 Feb; 165(9):52. PubMed ID: 15765852 [No Abstract] [Full Text] [Related]
24. [Cardiovascular risk: a class effect of coxibs? How to manage patients taking Vioxx?]. Brune K; Zacher J MMW Fortschr Med; 2004 Oct; 146(42):10, 12. PubMed ID: 15536697 [No Abstract] [Full Text] [Related]
25. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Couzin J Science; 2004 Oct; 306(5695):384-5. PubMed ID: 15486258 [No Abstract] [Full Text] [Related]
26. The vexations of Vioxx. Sibbald B CMAJ; 2006 Feb; 174(4):444-5. PubMed ID: 16477046 [No Abstract] [Full Text] [Related]
27. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag". Armstrong D Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016 [No Abstract] [Full Text] [Related]
29. NEJM stands by its criticism of Vioxx study. Tanne JH BMJ; 2006 Mar; 332(7540):505. PubMed ID: 16513694 [No Abstract] [Full Text] [Related]
30. Lessons learned after the withdrawal of rofecoxib. Giaquinta D Manag Care Interface; 2004 Nov; 17(11):25-6, 46. PubMed ID: 15573801 [No Abstract] [Full Text] [Related]
31. The lessons of Vioxx. Frazier KC N Engl J Med; 2005 Sep; 353(13):1420-1; author reply 1420-1. PubMed ID: 16192497 [No Abstract] [Full Text] [Related]
34. NEJM "failed its readers" by delay in publishing its concerns about VIGOR trial. Dobson R BMJ; 2006 Jul; 333(7559):116. PubMed ID: 16840463 [No Abstract] [Full Text] [Related]
35. Rofecoxib, Merck, and the FDA. Kim PS; Reicin AS N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625342 [No Abstract] [Full Text] [Related]